Pourjamal N, Yazdi N, Halme A, Joncour VL, et al. Comparison of trastuzumab emtansine, trastuzumab deruxtecan, and disitamab vedotin in a multiresistant HER2-positive breast cancer lung metastasis model. Clin Exp Metastasis 2024 Feb 17. doi: 10.1007/s10585-024-10278.
PMID: 38367127